75 related articles for article (PubMed ID: 7538247)
1. False-positive serum prostate-specific antigen values in a patient with non-Hodgkin lymphoma of the kidney.
Djavan B; Keffer JH; Molberg K; Roehrborn CG
Urology; 1995 May; 45(5):875-8. PubMed ID: 7538247
[TBL] [Abstract][Full Text] [Related]
2. Complete regression of cardiac non-Hodgkin lymphoma.
Morillas P; Quiles J; Nuñez D; Senent C; Martínez S; Fernández JA; Bertomeu V
Int J Cardiol; 2006 Jan; 106(3):426-7. PubMed ID: 16337063
[No Abstract] [Full Text] [Related]
3. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.
Lehrer S; Diamond EJ; Stagger S; Stone NN; Stock RG
Br J Cancer; 2002 Sep; 87(7):726-8. PubMed ID: 12232754
[TBL] [Abstract][Full Text] [Related]
4. [Primary, highly malignant B-cell lymphoma of the prostate. Apropos of a case and review of the literature].
Mounedji-Boudiaf L; Culine S; Devoldère G; Terrier-Lacombe MJ; Kattan J; Cazier A; Farhat F; Bekradda M; Droz JP
Bull Cancer; 1994 Apr; 81(4):334-7. PubMed ID: 7703552
[TBL] [Abstract][Full Text] [Related]
5. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging.
Weijs LE; Arsos G; Baarslag HJ; Wittebol S; de Klerk JM
Eur Heart J; 2007 Nov; 28(22):2698. PubMed ID: 17567624
[No Abstract] [Full Text] [Related]
6. [Non-Hodgkin lymphoma of the infratemporalis fossa: a case report].
Boulaich M; Oujilal A; Nazih N; Filali A; Lazrak A; Kzadri M
Rev Stomatol Chir Maxillofac; 2003 Dec; 104(6):347-51. PubMed ID: 14968099
[TBL] [Abstract][Full Text] [Related]
7. B-cell lymphoma of the larynx in a patient with rheumatoid arthritis.
Patiar S; Ramsden JD; Freeland AP
J Laryngol Otol; 2005 Aug; 119(8):646-8. PubMed ID: 16102224
[TBL] [Abstract][Full Text] [Related]
8. Prostate specific antigen response to mitoxantrone and prednisone in patients with refractory prostate cancer: prognostic factors and generalizability of a multicenter trial to clinical practice.
Dowling AJ; Czaykowski PM; Krahn MD; Moore MJ; Tannock IF
J Urol; 2000 May; 163(5):1481-5. PubMed ID: 10751862
[TBL] [Abstract][Full Text] [Related]
9. Primary non-Hodgkin's lymphoma of the gallbladder diagnosed by laparoscopic cholecystectomy.
Kato H; Naganuma T; Iizawa Y; Kitagawa M; Tanaka M; Isaji S
J Hepatobiliary Pancreat Surg; 2008; 15(6):659-63. PubMed ID: 18987940
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ
Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560
[TBL] [Abstract][Full Text] [Related]
11. Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion.
Piccaluga PP; Vigna E; Placci A; Agostinelli C; Laterza C; Papayannidis C; Leone O; Martinelli G; Zinzani PL; Baccarani M; Pileri SA
Br J Haematol; 2006 Aug; 134(4):356. PubMed ID: 16882130
[No Abstract] [Full Text] [Related]
12. [HIV-related multiple non-Hodgkin lymphomas].
Gotoh M; Kitahara T; Iguchi T; Izumi M; Mukai K; Ohyashiki K
Rinsho Ketsueki; 2008 Nov; 49(11):1552-5. PubMed ID: 19047787
[TBL] [Abstract][Full Text] [Related]
13. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
Morote J; Lorente JA; Encabo G
Cancer; 1996 Dec; 78(11):2374-8. PubMed ID: 8941009
[TBL] [Abstract][Full Text] [Related]
14. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
Miyata Y; Sakai H; Hayashi T; Kanetake H
Prostate; 2003 Feb; 54(2):125-32. PubMed ID: 12497585
[TBL] [Abstract][Full Text] [Related]
15. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
Haese A; Dworschack RT; Partin AW
J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
17. Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.
Määttänen L; Hakama M; Tammela TL; Ruutu M; Ala-Opas M; Juusela H; Martikainen P; Stenman UH; Auvinen A
Br J Cancer; 2007 Jan; 96(1):56-60. PubMed ID: 17213825
[TBL] [Abstract][Full Text] [Related]
18. Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation.
Gann PH; Ma J; Catalona WJ; Stampfer MJ
J Urol; 2002 Jun; 167(6):2427-34. PubMed ID: 11992051
[TBL] [Abstract][Full Text] [Related]
19. [A case of primary non-Hodgkin lymphoma of the lacrimal sac].
Buc D; Travade P; Kemeny JL; Bacin F
J Fr Ophtalmol; 2002 Nov; 25(9):931-5. PubMed ID: 12515939
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
